
|Articles|June 27, 2008
Lexiscan stress agent now available
Radionuclide imaging agent Lexiscan is now commercially available.
Advertisement
Astellas Pharma has announced the availability of regadenoson (Lexiscan injection) for use as a pharmacologic stress agent. Regadenoson was co-developed by CV Therapeutics and, according to the manufacturer, is the first A2A adenosine receptor agonist to be used in myocardial perfusion imaging. The new agent will be used for patients undergoing cardiac stress tests who are unable to exercise for medical reasons.
To see more Daily News articles,
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
From Policy to Practice: Elevating Pharmacy’s Role in Quality and Patient Safety
2
Trump Executive Order Set to Reclassify Marijuana, Improve CBD Access
3
REM-Dominant Sleep Apnea Is Significantly More Prominent Following COVID-19
4
Most Favored Nation: Global Benchmarking to Reimagine US Drug Distribution
5

















































































































